問題詳情
IV. 閱讀測驗 10% They lie buried- their long, tentaclelike arms outstretched—in all the tissues of our bodies that interact withthe environment. In the lining of our nose and lungs, lest we inhale the influenza virus in a crowded subway car.In our gastrointestinal tract, to alert our immune system if we swallow a dose of salmonella bacteria. And mostimportantly, in our skin, they lie in wait as stealthy sentinels should microbes breach the leathery fortress of ourepidermis. They are dendritic cells, a class of white blood cells that encompasses some of the least understood butmost fascinating actors in the immune system. Over the past several years, researchers have begun to unravelthe mysteries of how dendritic cells educate the immune system about what belongs in the body and what isforeign and potentially dangerous. Intriguingly, they have found that dendritic cells initiate and control theoverall immune response. For instance, the cells are crucial for establishing immunological “memory,” which isthe basis of all vaccines. Indeed, physicians, including those at a number of biotechnology companies, aretaking advantage of the role that dendritic cells play in immunization by “vaccinating” cancer patients withdendritic cells loaded with bits of their own tumors to activate their immune system against their cancer.Dendritic cells are also responsible for the phenomenon of immune tolerance, the process through which theimmune system learns not to attack other components of the body. Dendritic cells are relatively scarce: they constitute only 0.2 percent of white blood cells in the blood andare present in even smaller proportions in tissues such as skin. In part because of their rarity, their true functioneluded scientists for nearly a century after they were first identified in 1868 by German anatomist PaulLangerhans, who mistook them for nerve endings in the skin. In 1973 Ralph M. Steinman of the Rockefeller University rediscovered the cells in mouse spleens andrecognized that they are part of the immune system. The cells were unusually potent in stimulating immunity inexperimental animals. He renamed the cells “dendritic” because of their spiky arms, or dendrites, although thesubset of dendritic cells that occur in the epidermis layer of the skin are still commonly called Langerhans cells. There are several subsets of dendritic cells, which arise from precursors that circulate in the blood and thentake up residence in immature form in the skin, mucous membranes, and organs such as the lungs and spleen.Immature dendritic cells are endowed with a wealth of mechanisms for capturing invading microbes: they reelin invaders using suction cup-like receptors on their surfaces, they take microscopic sips of the fluid surroundthem, and they suck in viruses or bacteria by engulfing them in sacks known as vacuoles. Once they devourforeign objects, the immature cells chop them into fragments (antigens) that can be recognized by the rest of theimmune system. Dendritic cells are very efficient at capturing and presenting antigens: they can pick up antigens that occur inonly minute concentrations. As they process antigens for presentation, they travel to the spleen through theblood or to lymph nodes through a clear fluid known as lymph. Once at their destinations, the cells completetheir maturation and present their antigen-laden molecules to naïve helper T cells, those that have neverencountered antigens before. Dendritic cells are the only cells that can educate naïve helper T cells to recognizean antigen as foreign or dangerous. This unique ability appears to derive from costimulatory molecules on theirsurfaces that can bind to corresponding receptors on the T cells. Once educated, the helper T cells go on to prompt so-called B cells to produce antibodies that bind to andinactivate the antigen. The dendritic cells and helper cells also activate killer T cells, which can destroy cellsinfected by microbes. Some of the cells that have been educated by dendritic cells become “memory” cells thatremain in the body for years—to combat the invader in case it ever returns. Activating naive helper T cells is the basis of vaccines for everything from pneumonia to tetanus toinfluenza. Scientists are now turning the new knowledge of the role that dendritic cells play in immunity againstmicrobes and their toxins into a strategy to fight cancer. Cancer cells are abnormal and as such are thought to generate molecules that healthy cells don’t. Ifresearchers could devise drugs and vaccines that exclusively targeted those aberrant molecules, they couldcombat cancer more effectively while leaving normal cells and tissues alone—thereby eliminating some of thepernicious side effects of chemotherapy and radiation, such as hair loss, nausea and weakening of the immunesystem caused by destruction of the bone marrow. Such trials generally employ vaccines made of dendritic cells precursors that have been isolated from cancerpatients and grown in the laboratory together with tumor antigens. During this process, the dendritic cells pickup the antigens, chop them up and present them on their surfaces. When injected back into the patients, theantigen-loaded dendritic cells are expected to ramp up patients’ immune response against their own tumors. Several researchers fear that such vaccines might induce patients’ immune systems to attack healthy tissueby mistake. In addition, tailoring a dendritic cell vaccine to fight a particular patient’s tumors might not beeconomically feasible. But many scientists are working to circumvent the costly and time-consuming steps ofisolating cells from patients and manipulating them in the laboratory for reinjection. As we learn more about the molecules that control dendritic cells, we will find ways to harness theirtherapeutic potential. The increasing number of scientists and corporations working on dendritic cells portendsthat we will soon be able to maximize the biological power of these cells to treat and prevent the diseases thatplague humankind.[!--empirenews.page--]
41. Which is the best title for this article?
(A) Dendritic Cells- An Elixir for All
(B) The Long Arm of the Immune System
(C)An Introduction to Cancer Cures
(D) The Mechanisms for Creating Vaccines
41. Which is the best title for this article?
(A) Dendritic Cells- An Elixir for All
(B) The Long Arm of the Immune System
(C)An Introduction to Cancer Cures
(D) The Mechanisms for Creating Vaccines
參考答案
答案:B
難度:適中0.5
統計:A(0),B(0),C(0),D(0),E(0)
內容推薦
- 下列有關對不特定人募集之期貨信託基金得從事或投資之項目,何者正確?(A)得從事證券信用交易(B)投資於證券投資信託基金受益憑證之總金額,不得超過本基金淨資產價值百分之十(C)得向銀行財務融資從事衍
- 期貨信託事業運用所募集之期貨信託基金從事經主管機關核准之店頭衍生性商品,下列何者錯誤?(A)應確保取得交易之公平或合理價格並通知基金保管機構(B)交易之總風險暴露,除主管機關核准外,不得超過本期
- 1 相較於低含水量軟式水膠隱形眼鏡,高含水量鏡片比較具有下列何種特性?(A)不透氧 (B)鏡片的水分不容易蒸發(C)不容易沉澱物質 (D)有較低的屈光折射率(refractive index)
- III. 文意選填 10% Although suicide attacks started to be systematically used by terrorist organizati
- 有關期貨信託事業舉行廣告、公開說明會及其他營業促銷活動之規定,下列敘述何者錯誤?(A)藉主管機關對期貨信託基金募集之核准,作為保證受益憑證價值之宣傳(B)不得對於過去之業绩作誇大之宣傳(C)不得預
- 依「期貨信託基金管理辦法」,有關期貨信託事業對符合一定資格條件之人募集期貨信託基金之規 定,以下敘述何者正確?(A)可進行一般性廣告,也可透過銷售機構招募銷售(B)不可進行一般性廣告,但可透過銷
- VII. 英文作文 20% What makes an effective English teacher? Do you think it’s feasible to create a failur
- 【題組】(A) were born (B) may be born (C) may have been born (D) may not have been born
- 期貨信託事業非屬經營業務所需之資金,下列事項何者非其運用之範圍?(A)購買商業本票(B)購買國内政府債券(C)購買外國政府國庫券(D)存放銀行存款
- 「期貨信託基金管理辦法」第五十八條所稱「以主管機關指定之其他方式」,係指期貨信託事業對不 特定人募集期貨信託基金者,應將期貨信託基金之公開說明書、有關銷售之文件、期貨信託契約及最 近財務報表,傳
內容推薦
- 期貨信託事業之業務員從事之業務,包括:甲.辦理受益憑證之募集發行及銷售。乙.期貨交易及相關 投資之研究分析。丙.主辦會計。丁.執行基金之交易及投資。戊.内部稽核。己.基金之經營管理。上開 業務員
- ( )下列敘述何者錯誤?(A)比x小3的數,以(x-3)表示(B)比x大12的數,以(x+12)表示(C)x的 倍,以 表示(D)原價x元,打九折後的價錢以0.1x元表示
- 【題組】Which of the following is FALSE about dendritic cells?(A) Dendritic cells control the overal
- 有關期貨信託基金之規範,下列何者錯誤?(A)應與其事業及基金保管機構之自有財產分別獨立(B)不論專營或兼營之期貨信託事業均應將期貨信託基金交由基金保管機構保管(C)信託業兼營期貨信託事業,於符合
- 下列有關期貨信託事業之業務範圍敘述何者有誤?(A)辦理境外期貨基金之募集及銷售業務(B)運用期貨信託基金從事交易或投資(C)其他經金管會核准之有關業務(D)向不特定人或符合金管會所定資格條件之人
- 期貨信託事業減資退回股本後,資本額不得低於下列哪一個最低實收資本額?(A) 二億元(B)三億元(C)五億元(D)十億元
- 【題組】What are antigens?(A) Immature dendritic cells.(B) Foreign and potentially dangerous microbes
- 依「期貨信託基金管理辦法」之規定,期貨信託契約應報主管機關核准後予以終止之情形,不包括下 列何者?(A)期貨信託事業或基金保管機構解散、停業、歇業、許可遭撤銷或廢止(B)期貨信託事業與基金保管機
- 以下何者為期貨信託基金性質應記載之事項?(A)存續期間(B)期貨信託契約關係(C)投資地區及標的(D)是否分配收益
- 期貨信託事業持有已發行股份總數百分之五以上股東,除主管機關另有規定外,不得擔任其他期貨信 託事業之持有已發行股份總數百分之五以上之股東。其股份之計算不包括下列何種持股?(A)配偶(B)未成年子女(
- 【題組】Where is the most important guarding post for dendritic cells?(A) In the brain. (B) In the h
- 對不特定人募集期貨信託基金時,以下何種機構不得擔任基金銷售機構辦理基金銷售事宜?(A)符合「期貨信託基金管理辦法」所定資格條件之期貨經紀商(B)符合「期貨信託基金管理辦法」所定資格條件之信託業(
- 依「期貨信託基金管理辦法」之規定,對不特定人募集之期貨信託基金,當期貨信託契約終止時,期 貨信託事業應於主管機關核准清算後多久時間内,完成期貨信託基金之清算?(A)—個月(B) 二個月(C)三個
- 期貨信託事業募集期貨信託基金公開說明書關於期貨信託事業概況之事項,應記載最近幾年度募集之 基金、分公司及子公司之設立、董事、監察人或主要股東股權之移轉或更換、經營權之改變及其他重 要紀事?(A)—
- 有關保證型及保護型等保本型期貨信託基金之敘述,下列何者錯誤?(A)保證型期貨信託基金應經保證機構保證(B)保護型期貨信託基金係藉由期貨信託基金投資工具,於到期時提供受益人一定比率本金保護 之期貨
- 依「期貨信託基金管理辦法」之規定,專營期貨信託事業於取得許可證照後,最遲應於何時申請募集 期貨信託基金?(A)十五曰内(B)—個月内(C)三個月内(D)六個月内
- 期貨信託事業經理期貨信託基金得出借有價證券,下列有關敘述何者錯誤?(A)每一期貨信託基金出借持有任一有價證券數額不得超過所持有該有價證券總額之百分之五十(B)出借證券之借貸期間自借貸成交日起算,
- 當有何種情形時,對不特定人募集期貨信託基金之期貨信託事業全權委託其他專業機構運用期貨信託 基金,應立即將相關資訊傳送至主管機關指定之資訊申報網站公告?(A)終止與受委任機構之全權委託契約(B)變
- 期貨業商業同業公會之設立、組織及監督,除期貨交易法另有規定外,適用下列何種法律?(A)公司法(B)民法(C)證券交易法(D)商業圑體法
- 擬與其他期貨信託基金合併之期貨信託基金應符合哪些條件?甲.合併之期貨信託基金同為對不特定人 募集或同為對符合一定資格條件之人募集;乙.合併之期貨信託基金在運用期貨信託基金資產及執行交 易或投資上
- 依據「期貨信託基金管理辦法」之規定,其所指定辦理期貨信託事業之業務員在職訓練之機構為何?(A)財團法人中華民國證券暨期貨市場發展基金會(B)中華民國期貨業商業同業公會(C)台灣金融研訓院(D)臺
- 依我國期貨交易法,最重法定刑處七年有期徒刑之行為,以下何者不屬之?(A)期貨商有對作之行為(B)期貨商有詐欺之行為(C)期貨商對期貨交易人作獲利之保證(D)非期貨商受託從事期貨交易
- 期貨信託事業募集期貨信託基金公開說明書之内容如有虛偽或隱匿之情事者,依法應負責之人包括下 列何者?(A)期貨信託事業(B)期貨信託事業負責人(C)其他曾在公開說明書上簽章者(D)選項ABC皆是
- 依我國期貨交易法之規定,期貨業應於每會計年度終了後多久時間内,向主管機關申報内部控制聲 明書?(A)—個月(B)三個月(C)四個月(D)六個月
- 有關期貨信託事業得募集發行具資產配置理念之傘型期貨信託基金,對不特定人募集發行傘型期貨信 託基金規定,下列何者正確?(A)子期貨信託基金數不得超過五檔(B)每一子期貨信託基金得共同簽訂期貨信託契